Dr. Burgess spoke on the House Floor about the Motion to Concur in the Senate Amendment to H.R. 3630, the Middle Class Tax Relief and Job Creation Act of 2011, and the effect it will have on doctors and patients.
Read more
Washington, D.C. – Today, Congressman Michael C. Burgess, M.D. (TX-26), Vice Chair of the House Energy and Commerce Committee’s Subcommittee on Health and Chairman of the Congressional Health Care Caucus, released the following statement after voting in favor of the Middle Class Tax Relief and Job Creation Act, H.R. 3630. The legislation passed the House by a vote of 234 to 193.
Read more
Washington, D.C. – Today, Congressman Michael C. Burgess, M.D. (TX-26) launched his new website, burgess.house.gov.
“This one-stop-shop will provide information on what is happening in Congress, how my office can assist constituents, ways to contact me, and will provide the latest information on how legislation will affect North Texas,” said Dr. Burgess. “I encourage constituents to visit the new website and check back often as information will be updated regularly. This new website, in conjunction with the social media sites, will provide constituents with the most up-to-date information and resources.”
Read more
On December 5, 2011 Congressman Burgess, along with 69 Members of Congress, sent a letter to Chairman Dave Camp and Ranking Member Sander Levin, Committee on Ways and Means. To view the letter as a PDF click on the image below.
Read more
On November 16, 2011 Congressman Burgess along with 93 Members of Congress sent a letter to Speaker John Boehner, Majority Leader Eric Cantor, Minority Leader Nancy Pelosi, and Minority Whip Steny Hoyer. To view the letter as a PDF click on the image below.
Read more
Washington, D.C. – Yesterday, Congressman Michael C. Burgess, M.D. (TX-26) introduced two health care bills that will foster innovation and lead to job creation and growth. The Cultivating Scientific Expertise to Foster Innovation for Patients Act, H.R. 3206, and the Modernizing Laboratory Test Standards for Patients Act, H.R. 3207, are aimed at loosening excessive regulations on American manufactures and laboratories. The Energy and Commerce Committee prepared this memo summarizing the committee’s findings and the ten legislative solutions, two of which are the bills Dr. Burgess introduced.
Read more
Washington, D.C. – The Washington Times has published an op-ed by Congressman Michael C. Burgess, M.D. (TX-26), discussing how the Select Committee needs to puts the health care law on the table as they are with other entitlement programs. Dr. Burgess is the Vice Chair of the House Energy and Commerce Committee’s Subcommittee on Health and Chairman of the Congressional Health Care Caucus. You can view the op-ed below. To read it online click here.
Read more
Washington, D.C. – Last night, Congressman Michael C. Burgess, M.D. (R–Texas) and Congressman Ron Kind (D–Wisconsin) introduced the Immunosuppressive Drug Coverage for Kidney Transplant Patients Act. This legislation, H.R. 2969 will allow individuals who are eligible for immunosuppressive drugs under Medicare Part B to continue to receive their vital treatment past the 36-month cutoff. Without these drugs, transplant recipients are at risk to lose their transplanted kidneys – which too often happens.
Read more
